Frontage Expands Genomics Services Through the Acquisition of Ocean Ridge Biosciences
News provided by
Share this article
Share this article
EXTON, Pa., April 19, 2021 /PRNewswire/ Frontage Laboratories, Inc. today announced the acquisition of Ocean Ridge Biosciences.
Ocean Ridge Biosciences, located in Deerfield Beach, Florida, provides genomic services to clients developing novel therapeutics, including complete service solutions for analysis of RNA expression, DNA polymorphisms, methylation, microbial composition, and protein biomarkers from a wide range of samples. The company s wet lab services are optimized for ultra-low input requirements and challenging sample types such as formalin-fixed paraffin-embedded tissues, skin swabs, and a variety of biofluids. Some of the core applications includes mechanism of action, lead optimization, biomarker discovery, and development of companion diagnostics.
Subscribe
Genome skimming approach shows promise in paper comparing DNA techniques By Hank Schultz FDA scientists have advanced the state of the art in the use of DNA identification techniques in a paper focusing on the verification of echinacea supplements. A gene skimming approach tested in the study showed promise over the up-to-now benchmark DNA barcoding techniques.
The paper, titled
HPLC‐UV, Metabarcoding and Genome Skims of Botanical Dietary Supplements: A Case Study in Echinacea, was published in the journal
Planta Medica. The research was performed by a team led by Dr. Sara Handy, PhD of the Office of Regulatory Science at FDA’s Center for Food Safety and Applied Nutrition. It compared the results obtained from the two DNA approaches with data generated by an accepted chemical analytical technique.
(1)
Toronto, Ontario (Newsfile Corp. - January 14, 2021) - Zonetail Inc. (TSXV: ZONE), (OTCQB: ZTLLF) ( Zonetail or the Company ) is pleased to announce it has signed an agreement with Avrok Laboratories, LLC. ( Avrok ), based in Los Angeles, California and Ostia Sciences Inc. ( Ostia ) based in Toronto, Ontario, for its mobile residential platform, offering COVID-19 testing in the comfort of your own home.
Avrok and Ostia have partnered in Canada to offer surveillance screening for Sars-CoV-2, the virus that causes COVID-19. This service is available in Canada exclusively through Infect No More (InfectNoMore.ca). Infect No More offers Avrok s Next Gen Sequencing ( NGS ) technology, which is 99% accurate and up to 74% more cost effective than other COVID-19 testing methods. The companies also offer standard RT-PCR screening. A big advantage of the Infect No More service is the use of Avrok s oral sample collection system, which is painless, easy and can be self-administered.
New variant of Sars-Cov-2 not impediment to vaccine development, says CCMB hindustantimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hindustantimes.com Daily Mail and Mail on Sunday newspapers.
NEW DELHI: Around 20 passengers and crew coming from Heathrow airport tested positive for Covid-19 virus at five international airports Delhi, Amritsar, Kolkata, Ahmedabad, and Chennai after all the passengers and crew of Air India flights from London were screened using RT-PCR test in the last two days.
All the swab samples have been sent to the National Institute of Virology, Pune, to check if the virus is of a different strain a more virulent one detected recently in south England.
While five flyers and crew tested positive at the IGI airport in Delhi, seven passengers and one crew member tested positive at the Amritsar international airport, even as two flyers at Kolkata, four at Ahmedabad, and one at Chennai tested positive on Tuesday.